Rare disease ethics: what do patients and doctors really think?

NCT ID NCT07314736

First seen Jan 04, 2026 · Last updated Jun 22, 2026 · Updated 26 times

Summary

This study gathers opinions from patients, families, healthcare providers, and researchers about the ethical challenges of small-scale, personalized treatments for rare neurological diseases. Researchers will interview 385 participants to identify key concerns and best practices. The goal is to develop a framework that guides future ethical research in this area.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RARE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Jude Children's Research Hospital

    RECRUITING

    Memphis, Tennessee, 38105, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could create a best-practice framework for ethically conducting personalized treatments for children with rare neurological diseases.

What could go wrong

This is an observational interview study, not a treatment trial. It may not lead to immediate medical breakthroughs, and the framework developed may not be universally accepted.

Conditions

The condition(s) this trial relates to.

nervous system disorder Rare Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.